BANCR and familial pancreatic carcinoma: In conclusion, our study demonstrates the potential of BANCR as a promising new diagnostic and therapeutic target for pancreatic cancer and reveals the therapeutic effect of STM2457 on pancreatic cancer mediated by inhibiting BANCR expression.